Cardiovascular Systems (CSII) Tops Q1 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/14/2026
- Nasdaq drags on Wall St as AI slowdown fears hammer Nvidia, chipmakers
- Global AI stocks fall as industry chiefs call for slowing development
- Trump slams Anthropic CEO over AI slowdown call
- Oil prices soar over 4% to 16-week high after Saudi strikes
- BofA sees just 2% upside for the S&P 500 over the next 12 months
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Cardiovascular Systems (CSII) Guides Low 2Q16 Given Lingering Headwinds; Needham & Company Reiterates Buy
November 5, 2015 7:12 AM ESTNeedham & Company reiterated a Buy rating on Cardiovascular Systems (NASDAQ: CSII), and raised the price target to $19.00 (from $18.00), following the company's 1Q16 earnings report. Revenue was $43.9M (up 11% Y/Y after accounting for the end of the Asahi distribution agreement) vs. guidance of $43.9M and EPS was... More
